Literature DB >> 20614275

Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.

Gretchen S Folk1, Stephen B Williams, Robert B Foss, Julie C Fanburg-Smith.   

Abstract

Sclerosing epithelioid fibrosarcoma (SEF) has distinctive morphology and occurs mainly in deep soft tissue of adult extremities. Approximately 59 cases of SEF have been reported, with only 12 previously described in head and neck locations. Lesions involving the oral and maxillofacial region (OMFR) and intraosseous examples are rare. We present five cases of OMFRSEF. The OMF Pathology Department Registry was searched for cases coded from 1990 to the present as "SEF," "fibrosarcoma not otherwise specified" or "neoplasm of uncertain histiogenesis." Inclusion required OMFR location, an abundantly sclerotic sarcoma with epithelioid features, and lack of other phenotype by immunohistochemistry. Five cases of SEF included 3 males and 2 females. The age of the patients were: 19, 22, 35, 47 and 47 years. Tumor location included the infra-temporal fossa, buccal mucosa (recurrence extending into bone), anterior mandible (intraosseous primary, focally extending into soft tissue), and left parotid and submandibular gland (with metaplastic bone) regions. Tumor sizes ranged from 1.0 to 5.7 cm, median 3.5 cm. Histologically, the tumors were well delineated and multinodular, separated by fibrous septae. The spindled to primarily epithelioid tumor cells formed moderately cellular sheets and cords of irregularly contoured medium to large, round to oval, occasionally overlapping nuclei, indistinct nucleoli, wispy eosinophilic (retracting) cytoplasm, and distinctive cytoplasmic borders, embedded in osteoid-like stroma. Hemangiopericytoid (HPC-like) vessels were observed. Despite numerous apoptotic cells, mitoses were generally low; necrosis was present in two cases. Three tumors were graded as 2/3 and two 1/3. Immunohistochemically, the tumor cells were positive for vimentin, 1 case focally for CD34, whereas all cases were negative for S100 protein, keratins, EMA, desmin, and SMA. Wide or radical excision was performed with no adjuvant therapy. Follow-up revealed that 4 cases recurred at a range of 12-120 months. One case had no recurrent/residual disease at 3 months. Metastatic disease was present in 2 cases, to chest wall and lumbar/thoracic spine at 12 and 21 months, respectively. One patient died of disease complications at 15 months. OMFRSEF occur in adults in various locations, but with a common propensity to involve bone; there is recurrent potential and morbidity with higher grade lesions. The differential diagnosis for these tumors in this site includes sclerosing carcinoma, Ewing/PNET, osteosarcoma, osteoblastoma, and benign and malignant myoepithelial salivary gland tumors. The collagen, focal spindle cell features, HPC-like vasculature, and weak focal CD34 reactivity in one case might have raised a possible relationship between OMFRSEF and low grade malignant solitary fibrous tumor, but the intraosseous propensity, epithelioid features and relative lack of CD34 make this a distinctive entity.

Entities:  

Keywords:  Maxillofacial; Oral; Sarcoma; Sclerosing epithelioid fibrosarcoma

Mesh:

Substances:

Year:  2007        PMID: 20614275      PMCID: PMC2807507          DOI: 10.1007/s12105-007-0002-9

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  16 in total

1.  Immunohistochemistry.

Authors:  S M Hsu
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor.

Authors:  C R Antonescu; M K Rosenblum; P Pereira; A G Nascimento; J M Woodruff
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

3.  Sclerosing epithelioid fibrosarcomas involving the neuraxis: report of three cases.

Authors:  M H Bilsky; A C Schefler; D I Sandberg; I J Dunkel; M K Rosenblum
Journal:  Neurosurgery       Date:  2000-10       Impact factor: 4.654

Review 4.  Sclerosing epithelioid fibrosarcoma: a cytogenetic, immunohistochemical, and ultrastructural study of an unusual histological variant.

Authors:  L R Donner; K Clawson; S M Dobin
Journal:  Cancer Genet Cytogenet       Date:  2000-06

Review 5.  Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases.

Authors:  S M Scott; H M Reiman; D J Pritchard; D M Ilstrup
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

6.  Sclerosing epithelioid fibrosarcoma primary of the bone.

Authors:  Ihab Abdulkader; José Cameselle-Teijeiro; Máximo Fraga; Ana Caparrini; Jerónimo Forteza
Journal:  Int J Surg Pathol       Date:  2002-07       Impact factor: 1.271

7.  Epithelioid fibrosarcoma of the ovary.

Authors:  Kazuo Watanabe; Toshimitsu Suzuki
Journal:  Virchows Arch       Date:  2004-08-19       Impact factor: 4.064

8.  Sclerosing epithelioid fibrosarcoma with der(10)t(10;17)(p11;q11).

Authors:  Akira Ogose; Hiroyuki Kawashima; Hajime Umezu; Tetsuo Hotta; Wenguang Gu; Hiroshi Yamagiwa; Tomoyuki Ito; Tsuyoshi Tohyama; Hirokazu Nishijima; Naoto Endo
Journal:  Cancer Genet Cytogenet       Date:  2004-07-15

9.  Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.

Authors:  Andrew L Folpe; Jesse K McKenney; Julia A Bridge; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

Review 10.  Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature.

Authors:  L T C Chow; Y H Lui; S M Kumta; P W Allen
Journal:  J Clin Pathol       Date:  2004-01       Impact factor: 3.411

View more
  11 in total

1.  Sclerosing epithelioid fibrosarcoma of the oral cavity.

Authors:  Camille T Elkins; Paul E Wakely
Journal:  Head Neck Pathol       Date:  2011-06-21

Review 2.  Ear and Temporal Bone Pathology: Neural, Sclerosing and Myofibroblastic Lesions.

Authors:  A N Flaman; J K Wasserman; D H Gravel; B M Purgina
Journal:  Head Neck Pathol       Date:  2018-08-01

3.  Sclerosing Epithelioid Fibrosarcoma of the Jaw: Late Recurrence from a Low Grade Fibromyxoid Sarcoma.

Authors:  Catherine Laliberte; Iona T Leong; Howard Holmes; Eric A Monteiro; Brian O'Sullivan; Brendan C Dickson
Journal:  Head Neck Pathol       Date:  2017-12-22

Review 4.  ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.

Authors:  Yaping Luo; Wendi Hu; Huanwen Wu; Huadan Xue; Li Huo; Fang Li; Yupei Zhao; Menghua Dai
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  An aggressive solitary fibrous tumor with evidence of malignancy: a rare case report.

Authors:  S Vimi; V A Punnya; H Kaveri; K Rekha
Journal:  Head Neck Pathol       Date:  2008-07-31

Review 6.  Solitary myofibroma of the mandible: an immunohistochemical and ultrastructural study with a review of the literature.

Authors:  Takafumi Satomi; Michihide Kohno; Ai Enomoto; Harutsugu Abukawa; Ko Fujikawa; Toshiyuki Koizumi; Daichi Chikazu; Jun Matsubayashi; Toshitaka Nagao
Journal:  Med Mol Morphol       Date:  2013-11-09       Impact factor: 2.309

7.  Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.

Authors:  Kemal Kosemehmetoglu; Fisun Ardic; Scott E Kilpatrick; Ustun Aydingoz; Vaiyapuri P Sumathi; Michael Michal
Journal:  Virchows Arch       Date:  2020-10-21       Impact factor: 4.064

8.  Skull sclerosing epithelioid fibrosarcoma: A case report and review of the literature.

Authors:  Jingjing Xu; Jiawei Wang; Minming Zhang; Baizhou Li
Journal:  Oncol Lett       Date:  2016-03-29       Impact factor: 2.967

Review 9.  Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.

Authors:  Esther Baranov; Jason L Hornick
Journal:  Head Neck Pathol       Date:  2020-01-16

10.  Sclerosing Epithelioid Fibrosarcoma of the Coccyx: A Case Report and Review of Literature.

Authors:  Ajay Popli; Rajat Mahajan; Tarush Rustagi; Saransh Gupta; Vivek Verma; Hemant Gupta
Journal:  Cureus       Date:  2018-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.